ACIP Recommends Resuming Use of Johnson & Johnson COVID-19 Vaccine
A committee of vaccine advisers to the CDC convened to discuss the risk of a rare blood clotting condition linked to the Johnson & Johnson COVID-19 vaccine.
Coronavirus News Roundup: Johnson and Johnson Resumes Vaccine in Europe, Rapid Antigen Test Now Available for OTC Purchase
Here’s a roundup of the latest coronavirus-related news.
Expert Insights on New ASHP Drug Diversion Guidelines
Patrick Yoder, PharmD, discusses the impacts of the impending ASHP guideline updates, how to build drug diversion processes, and the ways that technology can target drug diversion.
Johnson & Johnson to Resume Distribution of COVID-19 Vaccine in Europe
The European Medicines Agency determined that the benefits of Johnson & Johnson’s COVID-19 vaccine outweigh the risks. The vaccine is still paused in the United States.
This Week on Drug Topics: April 19 to April 23
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Walgreens to Sell Abbott’s OTC COVID-19 Rapid Antigen Test
Beginning this week, the OTC self-administered rapid antigen test will be available in Walgreens stores for $23.99.
Coronavirus News Roundup: Pharmacists Can Improve Vaccine Uptake; FDA and CDC Recommend Pause for Johnson & Johnson Vaccine
Here's a roundup of the latest coronavirus-related news.
This Week on Drug Topics: April 12 to April 16
Coronavirus News Roundup: COVID-19 Therapy Pipeline Update, FDA Boosts Max Doses in Vials of Moderna Vaccine
Here's the roundup of COVID-19 related news from this week.
Optimize Pharmacy Technician Roles In Immunization, Patient Care Services
What workflow is best for your pharmacy team?
This Week on Drug Topics: April 5 to April 9
Pharma Logistics Wins Department of Defense Contract to Provide Pharmaceutical Reverse Distribution Services
Pharma Logistics announced it has secured the Pharmaceutical Reverse Distribution Program with the Department of Defense.
Coronavirus News Roundup: Pfizer Releases More Data on COVID-19 Vaccine
Understanding DTC and Telehealth in Pharmacy
How can pharmacies adapt to patients’ changing needs and embrace this evolution of care moving forward?
This Week on Drug Topics: March 29 to April 2
Coronavirus News Roundup: A Look at ‘Vaccine Arm’; AstraZeneca’s COVID-19 Vaccine Data Update
PBM Reform Legislation Progresses in Michigan
NCPA applauded the Michigan’s House passage of the legislation, which would reform many PBM reimbursement practices in the state.
AstraZeneca Reports Up-to-Date COVID-19 Vaccine Efficacy Results
The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.
AstraZeneca’s COVID-19 Vaccine Data Show 79% Efficacy Against Symptomatic Disease
AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.
CDC Report: Most Individuals Complete 2-Dose COVID-19 Vaccine Series
The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.
This Week on Drug Topics: March 22 to 26
Coronavirus News Roundup: European Countries Suspend Use of AstraZeneca’s COVID-19 Vaccine, CMS Increases Medicare Reimbursement for COVID-19 Vaccines
CMS Increases Medicare Reimbursement Rate for COVID-19 Vaccines
NCPA lauded the higher reimbursement rate in a statement.
This Week on Drug Topics: March 15 to 19
Coronavirus News Roundup: Many US Adults Prefer Pharmacies for COVID-19 Vaccination, CDC Issues Guidance for Fully Vaccinated Americans
Drug Topics® Introduces Complementary Independent Pharmacy Resource Total Pharmacy®
Total Pharmacy® will run as an insert in the Drug Topics® publication and host content in an additional online environment.
AmerisourceBergen Releases 2020 Global Sustainability Report
Company launches new Global Sustainability microsite and ESG Reporting Index .
This Week on Drug Topics: March 8 to 12
Coronavirus News Roundup: FDA Authorizes Johnson & Johnson Vaccine; Biden Pledges Vaccine Supply for All US Adults by End of May
NCPA: Most Adults Prefer Local Pharmacist Over Mail Order
Results of a new national survey showed that more than 8 in 10 adults prefer their local pharmacists over mail order services.
